Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Complex responses to inflammatory oxidants by the probiotic bacterium Lactobacillus reuteri

Poulami Basu Thakur, Abagail R. Long, Benjamin J. Nelson, Ranjit Kumar, Alexander F. Rosenberg, View ORCID ProfileMichael J. Gray
doi: https://doi.org/10.1101/605881
Poulami Basu Thakur
aDepartment of Microbiology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abagail R. Long
aDepartment of Microbiology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin J. Nelson
bAuburn University, Auburn, AL 36849
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ranjit Kumar
cCenter for Clinical and Translational Sciences, University of Alabama at Birmingham, Birmingham, AL 35294
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander F. Rosenberg
aDepartment of Microbiology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294
dInformatics Institute, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Gray
aDepartment of Microbiology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael J. Gray
  • For correspondence: mjgray@uab.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

ABSTRACT

Inflammatory diseases of the gut are associated with increased intestinal oxygen concentrations and high levels of inflammatory oxidants, including hydrogen peroxide (H2O2) and hypochlorous acid (HOCl), which are antimicrobial compounds produced by the innate immune system. This contributes to dysbiotic changes in the gut microbiome, including increased populations of pro-inflammatory enterobacteria (Escherichia coli and related species) and decreased levels of health-associated anaerobic Firmicutes and Bacteroidetes. The pathways for H2O2 and HOCl resistance in E. coli have been well-studied, but little is known about how commensal and probiotic bacteria respond to inflammatory oxidants. In this work, we have characterized the transcriptomic response of the anti-inflammatory, gut-colonizing Gram-positive probiotic Lactobacillus reuteri to both H2O2 and HOCl. L. reuteri mounts distinct responses to each of these stressors, and both gene expression and survival were strongly affected by the presence or absence of oxygen. Oxidative stress response in L. reuteri required several factors not found in enterobacteria, including the small heat shock protein Lo18, polyphosphate kinase 2, and RsiR, an L. reuteri-specific regulator of anti-inflammatory mechanisms. These results raise the intriguing possibility of developing treatments for inflammatory gut diseases that could sensitize pro-inflammatory enterobacteria to killing by the immune system while sparing anti-inflammatory, health-associated species.

IMPORTANCE It is becoming increasingly clear that effective treatment of inflammatory gut diseases will require modulation of the gut microbiota. Preventing pro-inflammatory bacteria from blooming while also preserving anti-inflammatory and commensal species is a considerable challenge, but our results suggest that it may be possible to take advantage of differences in the way different species of gut bacteria resist inflammatory oxidants to accomplish this goal.

INTRODUCTION

Inflammatory diseases of the gut (e.g. inflammatory bowel disease [IBD], Crohn’s disease, irritable bowel syndrome [IBS], etc.) are a rapidly growing health concern for which few effective treatment options are available (1–3). It has become increasingly clear that the bacterial populations inhabiting the gut play a key role in causing and perpetuating gut inflammation, with an emerging consensus that blooms of facultatively anaerobic enterobacteria (e.g. Escherichia coli) take advantage of changes in the nutritional and redox environment of the inflamed gut to outcompete the obligate anaerobes associated with a healthy gut flora (4–8). The redox changes in the inflamed gut include not only increases in oxygen levels (6, 7), but also the production of reactive oxygen, nitrogen, and chlorine species (ROS, RNS, RCS), which are antimicrobial oxidants that can shift the population structure of the microbiome and are major contributors to host tissue damage (9–12). Treatments that interfere with the ability of enterobacteria to thrive in the inflamed gut reduce both the changes in the microbiome and the symptoms of disease (1, 13), indicating that manipulating gut bacteria is an important element in controlling these diseases.

Probiotics are live microorganisms which, when consumed in sufficient quantities, have a measurable health benefit (14), and a variety of different probiotic bacteria have been shown to have anti-inflammatory effects in the gut (15, 16). The most commonly used probiotics are lactic acid bacteria of the genus Lactobacillus (17), which are able to both modulate the host immune system and outcompete enterobacterial pathogens (15), and some strains of which have been shown to improve outcomes for inflammatory bowel diseases in both humans and animal models (18–20). The effectiveness of probiotics for treating inflammation in the gut, however, may be limited by their ability to survive attack by the overactive host immune system, including the oxidative damage caused by ROS and RCS. While the general stress response physiology of lactic acid bacteria has been relatively well characterized (21), bacterial responses to oxidative stress are best understood in E. coli and related inflammation-enriched enterobacteria (22–25). This is especially true of RCS, including hypochlorous acid (HOCl) and reactive chloramines, which are extremely potent antimicrobial compounds produced by the neutrophil enzyme myeloperoxidase (22, 26–28). Relatively little is known about how health-associated probiotic and commensal bacteria sense and respond to inflammatory oxidants (21, 29–31).

Lactobacillus reuteri is a well-established model probiotic bacterium that is able to stably colonize the mammalian intestine (32, 33), where it combats inflammation and enteric infections by several different mechanisms, including anti-inflammatory histamine synthesis (34–37), modulation of immune cell functions (33, 38–40), and production of antimicrobial compounds (e.g. reuterin, reutericyclin)(37, 41, 42). While the genome-wide stress responses of L. reuteri to low pH (43) and bile salts (44, 45) have been characterized, little is known about how this organism responds to ROS, and nothing is known about how L. reuteri or any other lactic acid bacterium senses or responds to RCS. The L. reuteri genome encodes neither catalase nor superoxide dismutase (49). The oxidative stress repair enzyme methionine sulfoxide reductase (46) is induced by and required for gut colonization by L. reuteri (47, 48), indicating that resistance to oxidative damage is important in vivo. A cysteine-dependent pathway contributing to H2O2 and O2 tolerance has been identified (50), but did not appear to play a role in the ability of L. reuteri to prevent colitis (51).

In this work, we have now taken a transcriptomic approach to characterize genome-wide H2O2- and HOCl-dependent gene regulation in L. reuteri and to identify genes involved in resistance to killing by these stressors (52), with the goal of finding genes and pathways distinct from those found in the enterobacteria. Our results show that, despite not containing close homologs of any of the known RCS-specific transcription factors (22, 53–56), L. reuteri is able to mount clearly different stress responses to H2O2 and HOCl stress, and that the presence of O2 has dramatic effects on both gene regulation and survival in response to these stresses. We also identified roles for several genes in surviving H2O2- and HOCl-mediated killing, including those encoding methionine sulfoxide reductase (46), polyphosphate kinase 2 (57, 58), and the lactic acid bacteria-specific small heat shock protein Lo18 (59–61), as well as an unexpected role in surviving H2O2 stress for RsiR, previously characterized as an L. reuteri-specific regulator of histamine synthesis (35). Ultimately, we hope these results will help lay the groundwork for the development of targeted treatments for inflammatory gut diseases that could either preferentially sensitize disease-associated enterobacteria to killing by the immune system or preferentially protect health-promoting probiotic and commensal species, thereby stabilizing the healthy microbiome against inflammatory stress.

RESULTS AND DISCUSSION

Growth of L. reuteri is inhibited by inflammatory oxidants

To begin characterizing the response of L. reuteri to inflammatory oxidants, we treated anaerobically growing cultures with different concentrations of H2O2 (Fig. 1A) and HOCl (Fig. 1B). L. reuteri growth was more sensitive to H2O2 than HOCl, with nearly complete inhibition by 0.96 mM H2O2 or 5 mM HOCl. The sensitivity of L. reuteri to H2O2 was very similar to that reported for L. acidophilus, another catalase-negative probiotic (31), but, as expected, L. reuteri was considerably more sensitive to H2O2 than the pseudocatalase-expressing species L. plantarum (62, 63). Since we were interested in characterizing gene regulation during a successful, productive response to sublethal stress, we selected concentrations of 0.12 mM H2O2 and 1.25 mM HOCl for further analysis. These concentrations resulted in very similar slight reductions in growth rate after stress treatment, followed by complete recovery (Fig. 1A and B, red circles). These concentrations of oxidants had no significant effect on cellular NAD+ / NADH ratios (Fig. 1C, 1D, and S1), indicating that the toxic effects of sublethal H2O2 and HOCl stress did not include major disruptions to the redox state of the bacterial cells.

FIG 1
  • Download figure
  • Open in new tab
FIG 1

Growth of L. reuteri is inhibited by inflammatory oxidants. L. reuteri ATCC PTA 6475 was grown anaerobically at 37°C to A600=0.3–0.4 in MEI-C and then treated with the indicated concentrations of H2O2 (A, C) or HOCl (B, D) (n=3, ±SD). A600 (A, B) or NAD+ / NADH ratios were measured at the indicated times. Red symbols indicate the stress treatments used for subsequent transcriptomic analyses.

Transcriptomic analysis of H2O2 and HOCl response by L. reuteri

We next treated anaerobically growing L. reuteri with sublethal doses of H2O2 and HOCl and used RNA sequencing to characterize the transcriptomes of stressed cells before and 5, 15, and 30 minutes after stress treatment (Fig. 2, Table S1). A very large fraction of the L. reuteri genome was up- or down-regulated (> 2-fold, p < 0.01) by sublethal oxidative stress, and there were clear differences in the responses to H2O2 and HOCl, consistent with previous reports that bacterial responses to these oxidants are different (22–24). As seen in Figure 2, the response to H2O2 involved roughly equal numbers of up- and downregulated genes, with a substantial increase in the number of genes with significant changes in expression over the 30 minute course of stress treatment. In contrast, HOCl treatment caused many more genes to be upregulated than downregulated, and there was not as noticeable an increase in the number of genes with significant changes in gene expression over time, consistent with the very fast reaction rate of HOCl with biological molecules (22, 27, 64). The difference between the H2O2 and HOCl stress responses were also reflected in principal components analysis of the transcriptomic data (Fig. S2A), which clearly separated the H2O2 and HOCl treated samples. The untreated samples from the two experiments did not cluster as closely together as we expected, since these samples were ostensibly identical. To determine whether this reflected batch effects or inherent variation in expression levels for particular genes, we selected representative genes that had similar (sigH, moeB, pcl1) or different (pstS, copR) levels of expression in the untreated samples from the two RNA-seq data sets (Table S1) and used RT-PCR to measure their expression in independently prepared unstressed L. reuteri cultures, and found that the amount of variation in expression was similar for all five genes (Fig. S2B).

FIG 2
  • Download figure
  • Open in new tab
FIG 2

Volcano plot of log2-fold changes in gene expression in anaerobically-grown L. reuteri ATCC PTA 6475 treated with 0.12 mM H2O2 or 1.25 mM HOCl 5, 15, and 30 minutes after stress treatment. −log10 p-value is plotted against log2 gene expression ratio for H2O2-treated (left column) and HOCl-treated (right column) cultures for three time-points relative to their baseline (rows). Vertical red lines indicate +/- 2-fold changes. Horizontal red dashed line corresponds to p = 0.01.

To further characterize the differences and overlaps between the H2O2 and HOCl stress responses of L. reuteri, we plotted changes in gene expression under each tested condition against each other condition (Fig. 3, Table S2). This showed that, while many of the genes significantly upregulated by H2O2 were also upregulated by HOCl, there were substantial numbers of genes that were upregulated by one stress treatment and downregulated by the other and vice versa, indicating that L. reuteri has a sophisticated ability to distinguish between H2O2 and HOCl and differentially control transcription. Clustering analysis of genome-wide expression patterns (Fig. 4) reinforced this result, and we were able to identify groups of genes whose expression was controlled in very similar ways by the different oxidants (e.g. Fig. 4B and G) as well as groups of genes with very different expression patterns in response to H2O2 and HOCl (e.g. Fig. 4C, D, and H), including, for example, cgl and cyuABC, which encode a previously characterized cysteine-dependent redox stress response pathway (50). This is consistent with results in E. coli and Bacillus subtilis, in which H2O2 and HOCl stress responses partially overlap, but have substantial oxidant-specific components (22, 27, 56, 64, 65).

FIG 3
  • Download figure
  • Open in new tab
FIG 3

Log2-fold changes in gene expression in anaerobically-grown L. reuteri ATCC PTA 6475 treated with 0.12 mM H2O2 (purple) or 1.25 mM HOCl (green) 5, 15, and 30 minutes after stress treatment. 15 pairwise comparisons of log2 ratios of six differential expression experiments. Each dot represents a gene and its position reflects the log2 ratio in each of two differential expression results. Horizontal lines represent +/- 2-fold changes. Orange points are genes with 2-fold changes in both differential expression data sets (not necessarily in the same directions). See Table S2 for individual genes in each expression category.

FIG 4
  • Download figure
  • Open in new tab
FIG 4

Clustering analysis of gene expression levels (FPKM) in anaerobically-grown L. reuteri ATCC PTA 6475 treated with 0.12 mM H2O2 (purple) or 1.25 mM HOCl (green) 0, 5, 15, and 30 minutes after stress treatment (times plotted outward from the center for each panel). Heat map showing row z-scores of rlog-transformed data (red = +2, blue = −2). Rows are 185 high-variance genes (out of 2010; variance > 0.5, after averaging triplicates), columns are treatment/time-points (left four columns are H2O2, right four columns are HOCl; time emanates from center along x-axis as indicated by triangles below plot). Rows are hierarchically clustered using Euclidean distance of z- score data and average linkage. Letters A-F are callouts of six example sets of four genes each whose expression data are shown in the six plots on the right. Solid lines are mean expression values (triplicates) and shaded regions indicate maximum and minimum values of triplicates for the corresponding treatment/time-point. Called-out genes are A: LAR_RS04660 (ribD), LAR_RS04665 (ribE), LAR_RS04670 (ribBA), LAR_RS04675 (ribH); B: LAR_RS03125, LAR_RS02625 (oxc), LAR_RS09770, LAR_RS10190; C: LAR_RS02280 (copA2), LAR_RS02285 (copA3), LAR_RS02290 (copA), LAR_RS09945; D: LAR_RS01550 (cgl), LAR_RS01555 (cyuA), LAR_RS01560 (cyuB), LAR_RS01565 (cyuC); E: LAR_RS08400, LAR_RS07525, LAR_RS07530, LAR_RS07535 (cwlA); F: LAR_RS05395 (moaD), LAR_RS05400 (moaE), LAR_RS05455, LAR_RS05460.

L. reuteri’s response to H2O2 was generally consistent with what has been previously observed in other catalase-negative Gram-positive bacteria (21, 23, 24, 31, 66–68). Highly upregulated genes included alkylhydroperoxidase (ahpCF)(69), NADH oxidase (noxE)(70), methionine sulfoxide reductase (msrB)(46), DNA repair genes (uvrABD, xthA, umuC)(71), predicted metal transporters (pcl1, pcl2), and the peroxide-sensing transcription factor PerR (68). The response to HOCl was also, in broad strokes, similar to that of previously characterized bacteria (22), in that upregulated genes included those involved in proteostasis (groSL, clpE, hsp20/lo18), metal stress (pcl1, pcl2, copAR), thioredoxins (trxABD), and cysteine and methionine synthesis (cysK, metE). Genes upregulated by both stressors included not only msrB, ahpCF, perR, and the predicted iron transporters encoded by pcl1 and pcl2, but a variety of predicted sugar and amino acid transporters and metabolic enzymes (oxc, encoding oxalyl-CoA decarboxylase (72), for example). These may represent responses to changes in the nutritional environment L. reuteri encounters in the inflamed gut (6, 8).

Redox-regulated transcription factors in L. reuteri

While many bacterial transcription factors have been described that respond to H2O2 and / or HOCl, L. reuteri encodes only a few homologs of known H2O2-detecting transcription factors (e.g. PerR and VicK (24, 67)) and no close homologs of any of the known HOCl-detecting transcription factors (22, 53–55, 68, 73). This suggested that among the 104 predicted transcription factors encoded by the L. reuteri genome (Table S3), there are likely to be novel redox-sensing regulators. To begin to assess this possibility, we performed clustering analysis on the expression of genes encoding transcription factors under both stress conditions (Fig. 5), reasoning that many bacterial transcription factors are autoregulated, and that changes in expression of transcription factors are useful signposts for identifying regulatory stress-response networks (53, 65, 74). We found genes encoding predicted transcription factors whose expression was activated by both H2O2 and HOCl (e.g. perR, spxA, LAR_RS09770), repressed by both H2O2 and HOCl (e.g. kdgR, fabT), activated only by H2O2 (e.g. lexA, LAR_RS07525), activated only by HOCl (e.g. ctsR, copR), repressed only by H2O2 (e.g. sigH, rex), and repressed only by HOCl (e.g. malR3, LAR_RS02755), indicating the presence of a complex regulatory response to both oxidants. Some of these regulators have known functions, which give useful insights into the in vivo effects of H2O2 and HOCl on L. reuteri. For example, only HOCl activated expression of ctsR, a conserved regulator of protein quality control in Gram positive bacteria (75, 76), consistent with the known ability of HOCl to unfold and aggregate proteins (77, 78) and the activation of the heat shock response in many species of HOCl-stressed bacteria (22). On the other hand, only H2O2 activated expression of the DNA-damage responsive lexA regulator (71), consistent with the known ability of H2O2 to damage DNA (23), and suggesting that HOCl does not cause DNA damage at the concentration used in this experiment. However, most of the transcription factors in L. reuteri have no known function, and the expression patterns of many of these genes were affected by the redox stress treatments. For example, the only alternative sigma factor (79) encoded in the L. reuteri genome (sigH) was downregulated strongly by H2O2, but unaffected by HOCl. We do not currently know what genes these uncharacterized regulators regulate, what role(s) they may play in surviving redox stress, or what transcription factor(s) are responsible for HOCl-specific regulation in L. reuteri.

FIG 5
  • Download figure
  • Open in new tab
FIG 5

Clustering analysis of gene expression for transcription factors in anaerobically-grown L. reuteri ATCC PTA 6475 treated with 0.12 mM H2O2 (purple) or 1.25 mM HOCl (green) 0, 5, 15, and 30 minutes after stress treatment. Heat map showing z-scores of rlog-transformed data (red = +2, blue = −2). Rows are 93 transcription factors where the adjusted p-value was < 0.01 for any of the within-treatment baseline time comparisons, columns are treatment/time-points (left four columns are H2O2, right four columns are HOCl; time emanates from center along x-axis as indicated by triangles below plot). Rows are hierarchically clustered using Euclidean distance of z-score data and average linkage. rlog-transformed expression data are shown for ten example transcription factors to the right of the heat map (lines are means, circles are individual replicates). Expression range of averaged replicates shown to left of heat map. See Table S3 for expression and log2-fold change values for all predicted transcription factors.

Oxygen affects H2O2- and HOCl-dependent gene expression in L. reuteri

We used quantitative RT-PCR to measure the changes in expression of selected genes in anaerobically grown L. reuteri treated with different concentrations of H2O2 and HOCl, at, above, and below the sublethal concentrations used in previous experiments (Fig. 6, left hand columns). We examined two genes strongly activated by both H2O2 and HOCl (ahpF and pcl1) and a gene repressed by both oxidants (moeB, encoding a subunit of molybdopterin synthase (80)) (Table S1) and confirmed the expected expression patterns. Interestingly, the genes differed in their dose-response patterns, with moeB roughly equally repressed at all H2O2 and HOCl concentrations, ahpF equally activated by all three H2O2 concentrations but activated more strongly by increasing doses of HOCl, and pcl1 activated more strongly at lower doses of H2O2 and at higher doses of HOCl. RT-PCR of the perR and sigH regulator genes also recapitulated the expression patterns seen in RNA-seq (Fig. 5), although at higher HOCl concentrations (2.5 mM), sigH expression began to be repressed, indicating that its control is not strictly H2O2- specific. Finally, we examined expression of rsiR, a known regulator of anti-inflammatory mechanisms in L. reuteri (34, 35) that was modestly upregulated by both H2O2 and HOCl in the RNA-seq experiment (Fig. S4), but we did not observe activation of rsiR expression in this follow-up experiment, indicating that expression of rsiR may not genuinely be redox-regulated under anaerobic conditions.

FIG 6
  • Download figure
  • Open in new tab
FIG 6

Dose-responsive control of gene expression by oxidative stress. L. reuteri ATCC PTA 6475 was grown anaerobically or microaerobically at 37°C to A600=0.3–0.4 in MEI-C and then treated with the indicated concentrations of H2O2 or HOCl. Change in expression of the indicated genes relative to untreated control cells was measured by quantitative RT-PCR (n=3, ±SD).

While the intestine is primarily an anaerobic environment (5), recent evidence suggests that inflammation, antibiotic treatment, and infection with enteric pathogens may increase the amount of oxygen available to microbes in the gut (6, 7). We therefore wanted to assess how much of an effect oxygen has on expression of redox regulated genes in L. reuteri. We repeated our RT-PCR experiment with microaerobic cultures, which were prepared aerobically and grown in full screw-cap tubes without shaking, low-oxygen conditions under which L. reuteri grows at a similar rate as under anaerobic conditions (data not shown). The results of this experiment (Fig. 6, right hand columns) revealed that the presence of even the low levels of oxygen expected in these cultures had large effects on redox-responsive gene expression. In contrast to what we observed anaerobically, expression of ahpF, pcl1, moeB, and sigH was unaffected by H2O2 under these conditions, and activation of perR was substantially reduced. HOCl activation of ahpF, pcl1, and perR expression was eliminated in the presence of oxygen, and both moeB and rsiR expression were HOCl-repressed. These results showed that oxygen can dramatically affect how bacteria regulate gene expression in response to inflammatory oxidants, and that studies of redox responses under aerobic growth conditions may not reflect how bacteria respond in anaerobic environments and vice versa.

Identifying genes important for surviving oxidative stress in L. reuteri

Finally, we wanted to use the gene expression data generated above to begin identifying genes involved in protecting L. reuteri against the toxicity of H2O2 and HOCl, based on the simple hypothesis that genes strongly upregulated by a certain stress may be involved in protecting the cell against that stress (81). We were particularly interested in identifying genes encoding factors that protect L. reuteri against HOCl, since much less is known about HOCl defense in bacteria in general (22), and no previous studies have examined how lactic acid bacteria survive reactive chlorine stress. We therefore identified lethal doses of H2O2 and HOCl for L. reuteri (Fig. S3), and found that 1.5 mM H2O2 was sufficient to kill 99 – 99.9% of L. reuteri over the course of an hour both anaerobically and microaerobically. Anaerobic cultures of L. reuteri were killed by 7.5 mM HOCl, while microaerobic cultures died to a similar extent at only 2.5 mM HOCl, further demonstrating that oxygen influences how L. reuteri responds to toxic oxidants.

We constructed several strains containing null mutations of genes that we predicted to be involved in defense against either H2O2 or HOCl, based on known bacterial redox stress response mechanisms (22, 23, 53, 82) and on our transcriptomic data (Fig. S4, Table S4). We obtained mutants lacking msrB, perR, sigH, rsiR, lo18 (hsp20), which encodes a small heat shock protein found only in lactic acid bacteria (59, 60) and whose expression was more strongly activated by HOCl than by H2O2, ppk1 and ppk2, encoding two different kinases able to produce inorganic polyphosphate (polyP), which protects against HOCl-mediated protein damage in E. coli (57, 77, 83), rclA, encoding a conserved flavoprotein known to protect E. coli against HOCl (53), hslO, encoding the HOCl-activated chaperone Hsp33 (78), and LAR_RS09945, encoding a predicted oxidoreductase that was very strongly upregulated by HOCl, but not by H2O2. The ability of each of these strains to survive lethal oxidative stress was measured by comparison to the survival of the wild-type strain under the same conditions (Fig. 7).

FIG 7
  • Download figure
  • Open in new tab
FIG 7

Genes regulated by inflammatory oxidants affect survival of lethal oxidative stress in L. reuteri. Survival index (log10 CFU ml−1 of mutant strain minus the log10 CFU ml−1 of wild-type strain from the same experimental replicate) of anaerobically or microaerobically-grown msrB, perR, ppk1, ppk2, rclA, hslO, lo18, rsiR, sigH, and LAR_RS09945 null mutants at the indicated time points after addition of 1.5 mM H2O2 or 7.5 or 2.5 mM HOCl. Asterisks indicate survival indices significantly different from zero at the indicated time point (two-way repeated measures ANOVA with Holm-Sidak’s multiple comparisons test, * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001).

Anaerobically, the msrB mutant was extremely sensitive to lethal H2O2 treatment, as expected (23, 46), and the perR mutant, which is expected to have constitutively high expression of peroxide defense genes (84), was significantly protected. A mutant lacking rsiR was significantly more sensitive to killing by H2O2, suggesting that despite the fact that its expression may not be controlled by this oxidant (Fig. 6), it is important for surviving H2O2 treatment (35). Surprisingly, only the perR mutant was significantly more sensitive than wild-type to killing by HOCl under anaerobic conditions. However, knocking out lo18 had a significant and unexpected protective effect. This was particularly surprising since lo18 expression was strongly upregulated in response to HOCl (Table S4). Under microaerobic conditions, the results of survival assays were considerably different. There were only minor differences in survival of a lethal dose of H2O2 in microaerobic cultures for any of the mutants, with msrB, rsiR, and rclA mutants showing very small but statistically significant defects in survival at the 1-hour time point. In contrast, there were much more substantial differences in survival of lethal HOCl stress under microaerobic conditions. The msrB, perR, lo18 and ppk2 mutants had significant defects in HOCl stress survival under these conditions, and the rsiR, ppk1, and rclA mutants were, on average, slightly more sensitive than the wild-type. The perR and LAR_RS09945 mutants were significantly protected at the 20 minute timepoint, but this effect was lost at later time points. There was no difference in HOCl survival between the wild-type and sigH or hslO mutants. These results further emphasize that oxygen concentration has dramatic effects on oxidative stress survival, and that it will therefore be important to quantify what oxygen levels gut bacteria are exposed to in inflamed and non-inflamed gut environments (5–7) to understand what genes are likely to play roles in ROS and RCS resistance in vivo.

Screening mutants lacking HOCl-induced genes has successfully identified HOCl resistance factors in other bacterial species (53, 54, 56, 65), but this strategy had limited success in L. reuteri. Neither sigH nor LAR_RS09945 mutations, for example, had any effect on survival of the stresses which regulate their expression. In future work, a genome-wide mutant screening approach (e.g. transposon sequencing)(52) may be valuable for identifying additional genes required for H2O2 and HOCl stress survival. Nevertheless, our targeted mutagenesis approach did allow us to identify several important players in oxidative stress resistance. Clearly, methionine sulfoxide reductase is a major contributor to the ability of L. reuteri to survive oxidative stress both anaerobically and microaerobically, consistent with its enzymatic activity (46) and known role in colonization (47, 48). While PerR is relatively unimportant microaerobically, anaerobically it plays an key role in regulating H2O2 resistance, as expected (68), although for unknown reasons it appears that the constitutive overexpression of H2O2-resistance genes expected in a perR mutant is detrimental in the presence of HOCl.

L. reuteri-specific defenses against H2O2 and HOCl stress

The H2O2-sensitivity of the rsiR mutant was somewhat surprising, since this L. reuteri-specific gene has largely been characterized for its role in regulating the expression of the histamine-producing histidine decarboxylase locus of L. reuteri, where rsiR is essential for histamine-dependent anti-inflammatory phenotypes (34, 35). However, RsiR is a global regulator, activating and repressing transcription of 195 and 143 genes, respectively, many of which are involved in redox homeostasis (including ahpC, perR, and genes involved in cysteine and methionine synthesis)(35). It is currently unclear what signal(s) RsiR responds to, which RsiR-regulated genes contribute to H2O2 sensitivity, or what role H2O2 resistance plays in RsiR-dependent anti-inflammatory effects in vivo, and these are exciting questions for future research exploring the connections between inflammatory oxidants and anti-inflammatory probiotic mechanisms.

The small heat shock protein Hsp33 and the flavoprotein RclA are RCS-specific defense factors in E. coli (53, 78), so we were also surprised to find that mutations of these genes had no apparent effect on HOCl survival in L. reuteri, despite the fact that rclA expression was induced more strongly by HOCl treatment than by H2O2 (Table S4). This could be due to the redundant nature of RCS resistance mechanisms (22), or could reflect fundamental differences in RCS response between L. reuteri and E. coli. Supporting the second hypothesis is the fact that mutations in lo18 and ppk2, genes not found in E. coli, had very strong effects on HOCl survival. Lo18 is a chaperone found only in a subset of Lactobacillus and Oenococcus species that stabilizes proteins and membranes under heat and ethanol stress conditions (59, 60). While this could easily explain how Lo18 protects L. reuteri against the protein-unfolding activity of HOCl, as we saw under microaerobic conditions, it is much less intuitive why the presence of Lo18 sensitizes L. reuteri to HOCl anaerobically, and more work will be needed to understand the mechanism underlying this effect. PolyP plays a role in stress resistance and probiotic phenotypes in several different Lactobacillus species (85–90). In E. coli, the polyP kinase PPK (homologous to L. reuteri PPK1) is required for HOCl resistance (77), but deletion of ppk1 had only a modest, non-statistically significant effect on HOCl resistance in L. reuteri. In contrast, deletion of ppk2, which encodes an unrelated polyP kinase (PPK2) whose primary physiological role is generally thought to be in generating NTPs from NDPs or NMPs and polyP (57, 58), led to a highly significant defect in HOCl survival, albeit only in the presence of oxygen. Whether polyP production in response to HOCl stress is driven by PPK1 or PPK2 in L. reuteri remains to be determined, as does the relative importance of PPK2’s polyP- and NTP-synthesizing activities. PPK2 is not present in enterobacteria, but is found in many species of commensal bacteria (including lactobacilli, Bacteroidetes, and Clostridiacea)(58, 91, 92)

Our results clearly demonstrate that HOCl resistance in L. reuteri depends on different factors than in E. coli or B. subtilis. These differences may represent targets for differentially sensitizing gut bacteria to oxidative stress. Interestingly, the frontline IBD drug mesalamine has recently been shown to be an inhibitor of PPK1 (93), and it is tempting to speculate that mesalamine may therefore have a larger impact on the ability of enterobacteria to survive in the inflamed gut than on PPK2-encoding commensals, although more data will be needed to test this hypothesis.

CONCLUSIONS

Manipulating the microbiome is likely to be a key element in future treatments for inflammatory diseases of the gut. Development of such treatments will require a sophisticated understanding of how gut bacteria respond to changes in their environment. The differences we have now begun to uncover in oxidative stress response between anti-inflammatory, health-associated bacteria and pro-inflammatory, disease-associated species may present opportunities for new therapies. We hope our results will ultimately make it possible to sensitize enterobacteria to inflammatory oxidants while simultaneously protecting the healthy gut community.

MATERIALS AND METHODS

Bacterial strains and growth conditions

All strains and plasmids used in this study are listed in Table 1. All L. reuteri strains were derivatives of strain ATCC PTA 6475 (Biogaia)(94). Strain 6475rsiR-Stop (35) was a gift from James Versalovic (Baylor College of Medicine), and plasmid pJP042 (recT+ erm+)(94) was a gift from Jan-Peter van Pijkeren (University of Wisconsin – Madison). L. reuteri was grown at 37°C in MEI broth (86) without added cysteine (MEI-C) or on solid De Man, Rogosa, and Sharpe (MRS) agar (Difco). Anaerobic cultures were incubated in an anaerobic chamber (Coy Laboratory Products) in an atmosphere of 90% nitrogen, 5% CO2, and 5% H2 or in Hungate tubes prepared, inoculated, and sealed in that chamber. Liquid media were made anaerobic before use by equilibration for at least 24 hours in the anaerobic chamber. MRS plates for colony forming unit (CFU) plate counts were incubated in sealed containers made anaerobic using GasPakTM EZ sachets (Becton Dickinson). Microaerobic cultures were incubated aerobically without shaking in 16 x 125 mm screw-cap test tubes containing 15 ml of MEI-C. Details of H2O2 and HOCl stress treatments, transcript quantification, and phenotype analysis are described in the Supplemental Material.

View this table:
  • View inline
  • View popup
  • Download powerpoint
TABLE 1.

Strains and plasmids used in this study. Unless otherwise indicated, all strains were generated in the course of this work.

Molecular methods

Oligo-directed recombineering was used to construct null mutations in the chromosome of L. reuteri using the pJP042-encoded RecT recombinase as previously described (94). Null mutations were designed to incorporate in-frame stop codons near the 5’ end of each gene. Mutagenic primers used are listed in Table S5. Primers used for quantitative RT-PCR were designed with Primer Quest (www.idtdna.com; parameter set “qPCR 2 primers intercalating dyes” for qRT-PCR primer design) and are listed in Table S6. Additional primers for PCR amplification, screening, and sequencing were designed using WebPrimer (www.candidagenome.org/cgi-bin/compute/web-primer). All chromosomal mutations were confirmed by Sanger sequencing (UAB Heflin Center for Genomic Sciences).

Data availability

All strains generated in the course of this work are available from the authors upon request. RNA sequencing data have been deposited in NCBI’s Gene Expression Omnibus (95) and are accessible through GEO Series accession number GSE127961 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE127961).

ACKNOWLEDGEMENTS

We thank Drs. Rob Britton and James Versalovic (Baylor College of Medicine) and Dr. J.P. van Pijkeren (University of Wisconsin – Madison) for strains and plasmids. This project was supported by University of Alabama at Birmingham Department of Microbiology startup funds and NIH grant R35GM124590 (to M.J.G). The authors have no conflicts of interest to declare.

REFERENCES

  1. 1.↵
    Knox NC, Forbes JD, Van Domselaar G, Bernstein CN. 2019. The Gut Microbiome as a Target for IBD Treatment: Are We There Yet? Curr Treat Options Gastroenterol doi:10.1007/s11938-019-00221-w.
    OpenUrlCrossRef
  2. 2.
    Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, Sung JJY, Kaplan GG. 2018. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390:2769–2778.
    OpenUrlCrossRefPubMed
  3. 3.↵
    Pillai N, Dusheiko M, Burnand B, Pittet V. 2017. A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease. PLoS One 12:e0185500.
  4. 4.↵
    Major G, Spiller R. 2014. Irritable bowel syndrome, inflammatory bowel disease and the microbiome. Curr Opin Endocrinol Diabetes Obes 21:15–21.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Friedman ES, Bittinger K, Esipova TV, Hou L, Chau L, Jiang J, Mesaros C, Lund PJ, Liang X, FitzGerald GA, Goulian M, Lee D, Garcia BA, Blair IA, Vinogradov SA, Wu GD. 2018. Microbes vs. chemistry in the origin of the anaerobic gut lumen. Proc Natl Acad Sci U S A 115:4170–4175.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    Byndloss MX, Baumler AJ. 2018. The germ-organ theory of non-communicable diseases. Nat Rev Microbiol 16:103–110.
    OpenUrlPubMed
  7. 7.↵
    Rivera-Chavez F, Lopez CA, Baumler AJ. 2017. Oxygen as a driver of gut dysbiosis. Free Radic Biol Med 105:93–101.
    OpenUrlCrossRefPubMed
  8. 8.↵
    Stecher B. 2015. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection. Microbiol Spectr 3.
  9. 9.↵
    Bhattacharyya A, Chattopadhyay R, Mitra S, Crowe SE. 2014. Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev 94:329–54.
    OpenUrlCrossRefPubMed
  10. 10.
    Hansberry DR, Shah K, Agarwal P, Agarwal N. 2017. Fecal Myeloperoxidase as a Biomarker for Inflammatory Bowel Disease. Cureus 9:e1004.
  11. 11.
    Chami B, Martin NJJ, Dennis JM, Witting PK. 2018. Myeloperoxidase in the inflamed colon: A novel target for treating inflammatory bowel disease. Arch Biochem Biophys 645:61–71.
    OpenUrl
  12. 12.↵
    Kruidenier L, Kuiper I, Lamers CB, Verspaget HW. 2003. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol 201:28–36.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Zhu W, Winter MG, Byndloss MX, Spiga L, Duerkop BA, Hughes ER, Buttner L, de Lima Romao E, Behrendt CL, Lopez CA, Sifuentes-Dominguez L, Huff-Hardy K, Wilson RP, Gillis CC, Tukel C, Koh AY, Burstein E, Hooper LV, Baumler AJ, Winter SE. 2018. Precision editing of the gut microbiota ameliorates colitis. Nature 553:208–211.
    OpenUrlCrossRefPubMed
  14. 14.↵
    Morelli L, Capurso L. 2012. FAO/WHO guidelines on probiotics: 10 years later. J Clin Gastroenterol 46 Suppl:S1-2.
  15. 15.↵
    Engevik MA, Versalovic J. 2017. Biochemical Features of Beneficial Microbes: Foundations for Therapeutic Microbiology. Microbiol Spectr 5.
  16. 16.↵
    Lee IC, Tomita S, Kleerebezem M, Bron PA. 2013. The quest for probiotic effector molecules--unraveling strain specificity at the molecular level. Pharmacol Res 69:61–74.
    OpenUrlCrossRefPubMed
  17. 17.↵
    Duar RM, Lin XB, Zheng J, Martino ME, Grenier T, Perez-Munoz ME, Leulier F, Ganzle M, Walter J. 2017. Lifestyles in transition: evolution and natural history of the genus Lactobacillus. FEMS Microbiol Rev 41:S27–S48.
    OpenUrlCrossRef
  18. 18.↵
    Tomusiak-Plebanek A, Heczko P, Skowron B, Baranowska A, Okon K, Thor PJ, Strus M. 2018. Lactobacilli with superoxide dismutase-like or catalase activity are more effective in alleviating inflammation in an inflammatory bowel disease mouse model. Drug Des Devel Ther 12:3221–3233.
    OpenUrl
  19. 19.
    Abraham BP, Quigley EMM. 2017. Probiotics in Inflammatory Bowel Disease. Gastroenterol Clin North Am 46:769–782.
    OpenUrl
  20. 20.↵
    Ganji-Arjenaki M, Rafieian-Kopaei M. 2018. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review. J Cell Physiol 233:2091–2103.
    OpenUrl
  21. 21.↵
    Papadimitriou K, Alegria A, Bron PA, de Angelis M, Gobbetti M, Kleerebezem M, Lemos JA, Linares DM, Ross P, Stanton C, Turroni F, van Sinderen D, Varmanen P, Ventura M, Zuniga M, Tsakalidou E, Kok J. 2016. Stress Physiology of Lactic Acid Bacteria. Microbiol Mol Biol Rev 80:837–90.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    Gray MJ, Wholey WY, Jakob U. 2013. Bacterial responses to reactive chlorine species. Annu Rev Microbiol 67:141–60.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    Imlay JA. 2013. The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium. Nat Rev Microbiol 11:443–54.
    OpenUrlCrossRefPubMed
  24. 24.↵
    Imlay JA. 2015. Transcription Factors That Defend Bacteria Against Reactive Oxygen Species. Annu Rev Microbiol 69:93–108.
    OpenUrlCrossRefPubMed
  25. 25.↵
    Goemans CV, Vertommen D, Agrebi R, Collet JF. 2018. CnoX Is a Chaperedoxin: A Holdase that Protects Its Substrates from Irreversible Oxidation. Mol Cell 70:614–627 e7.
    OpenUrlCrossRef
  26. 26.↵
    Green JN, Chapman ALP, Bishop CJ, Winterbourn CC, Kettle AJ. 2017. Neutrophil granule proteins generate bactericidal ammonia chloramine on reaction with hydrogen peroxide. Free Radic Biol Med 113:363–371.
    OpenUrlCrossRefPubMed
  27. 27.↵
    Winterbourn CC, Kettle AJ, Hampton MB. 2016. Reactive Oxygen Species and Neutrophil Function. Annu Rev Biochem 85:765–92.
    OpenUrlCrossRefPubMed
  28. 28.↵
    Klebanoff SJ. 2005. Myeloperoxidase: friend and foe. J Leukoc Biol 77:598–625.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    Mishra S, Imlay JA. 2013. An anaerobic bacterium, Bacteroides thetaiotaomicron, uses a consortium of enzymes to scavenge hydrogen peroxide. Mol Microbiol 90:1356–71.
    OpenUrlCrossRefPubMed
  30. 30.
    Oberg TS, Ward RE, Steele JL, Broadbent JR. 2015. Transcriptome analysis of Bifidobacterium longum strains that show a differential response to hydrogen peroxide stress. J Biotechnol 212:58–64.
    OpenUrl
  31. 31.↵
    Calderini E, Celebioglu HU, Villarroel J, Jacobsen S, Svensson B, Pessione E. 2017. Comparative proteomics of oxidative stress response of Lactobacillus acidophilus NCFM reveals effects on DNA repair and cysteine de novo synthesis. Proteomics 17.
  32. 32.↵
    Walter J, Britton RA, Roos S. 2011. Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm. Proc Natl Acad Sci U S A 108 Suppl 1:4645–52.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    Mu Q, Tavella VJ, Luo XM. 2018. Role of Lactobacillus reuteri in Human Health and Diseases. Front Microbiol 9:757.
    OpenUrl
  34. 34.↵
    Gao C, Major A, Rendon D, Lugo M, Jackson V, Shi Z, Mori-Akiyama Y, Versalovic J. 2015. Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri. MBio 6:e01358–15.
    OpenUrl
  35. 35.↵
    Hemarajata P, Gao C, Pflughoeft KJ, Thomas CM, Saulnier DM, Spinler JK, Versalovic J. 2013. Lactobacillus reuteri-specific immunoregulatory gene rsiR modulates histamine production and immunomodulation by Lactobacillus reuteri. J Bacteriol 195:5567–76.
    OpenUrlAbstract/FREE Full Text
  36. 36.
    Thomas CM, Hong T, van Pijkeren JP, Hemarajata P, Trinh DV, Hu W, Britton RA, Kalkum M, Versalovic J. 2012. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One 7:e31951.
  37. 37.↵
    Jones SE, Versalovic J. 2009. Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol 9:35.
  38. 38.↵
    Roth D, Chiang AJ, Hu W, Gugiu GB, Morra CN, Versalovic J, Kalkum M. 2018. Two-carbon folate cycle of commensal Lactobacillus reuteri 6475 gives rise to immunomodulatory ethionine, a source for histone ethylation. FASEB J doi:10.1096/fj.201801848R:fj201801848R.
    OpenUrlCrossRef
  39. 39.
    Santos F, Spinler JK, Saulnier DM, Molenaar D, Teusink B, de Vos WM, Versalovic J, Hugenholtz J. 2011. Functional identification in Lactobacillus reuteri of a PocR-like transcription factor regulating glycerol utilization and vitamin B12 synthesis. Microb Cell Fact 10:55.
  40. 40.↵
    Cervantes-Barragan L, Chai JN, Tianero MD, Di Luccia B, Ahern PP, Merriman J, Cortez VS, Caparon MG, Donia MS, Gilfillan S, Cella M, Gordon JI, Hsieh CS, Colonna M. 2017. Lactobacillus reuteri induces gut intraepithelial CD4(+)CD8alphaalpha(+) T cells. Science 357:806–810.
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    Ganzle MG. 2004. Reutericyclin: biological activity, mode of action, and potential applications. Appl Microbiol Biotechnol 64:326–32.
    OpenUrlCrossRefPubMed
  42. 42.↵
    Spinler JK, Taweechotipatr M, Rognerud CL, Ou CN, Tumwasorn S, Versalovic J. 2008. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe 14:166–71.
    OpenUrlCrossRefPubMedWeb of Science
  43. 43.↵
    Lee K, Lee HG, Pi K, Choi YJ. 2008. The effect of low pH on protein expression by the probiotic bacterium Lactobacillus reuteri. Proteomics 8:1624–30.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    Whitehead K, Versalovic J, Roos S, Britton RA. 2008. Genomic and genetic characterization of the bile stress response of probiotic Lactobacillus reuteri ATCC 55730. Appl Environ Microbiol 74:1812–9.
    OpenUrlAbstract/FREE Full Text
  45. 45.↵
    Lee K, Lee HG, Choi YJ. 2008. Proteomic analysis of the effect of bile salts on the intestinal and probiotic bacterium Lactobacillus reuteri. J Biotechnol 137:14–9.
    OpenUrlCrossRefPubMed
  46. 46.↵
    Ezraty B, Aussel L, Barras F. 2005. Methionine sulfoxide reductases in prokaryotes. Biochim Biophys Acta 1703:221–9.
    OpenUrlCrossRefPubMedWeb of Science
  47. 47.↵
    Walter J, Chagnaud P, Tannock GW, Loach DM, Dal Bello F, Jenkinson HF, Hammes WP, Hertel C. 2005. A high-molecular-mass surface protein (Lsp) and methionine sulfoxide reductase B (MsrB) contribute to the ecological performance of Lactobacillus reuteri in the murine gut. Appl Environ Microbiol 71:979–86.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    Walter J, Heng NC, Hammes WP, Loach DM, Tannock GW, Hertel C. 2003. Identification of Lactobacillus reuteri genes specifically induced in the mouse gastrointestinal tract. Appl Environ Microbiol 69:2044–51.
    OpenUrlAbstract/FREE Full Text
  49. 49.↵
    Saulnier DM, Santos F, Roos S, Mistretta TA, Spinler JK, Molenaar D, Teusink B, Versalovic J. 2011. Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features. PLoS One 6:e18783.
  50. 50.↵
    Lo R, Turner MS, Barry DG, Sreekumar R, Walsh TP, Giffard PM. 2009. Cystathionine gamma-lyase is a component of cystine-mediated oxidative defense in Lactobacillus reuteri BR11. J Bacteriol 191:1827–37.
    OpenUrlAbstract/FREE Full Text
  51. 51.↵
    Atkins HL, Geier MS, Prisciandaro LD, Pattanaik AK, Forder RE, Turner MS, Howarth GS. 2012. Effects of a Lactobacillus reuteri BR11 mutant deficient in the cystine-transport system in a rat model of inflammatory bowel disease. Dig Dis Sci 57:713–9.
    OpenUrlPubMed
  52. 52.↵
    Perez-Sepulveda BM, Hinton JCD. 2018. Functional Transcriptomics for Bacterial Gene Detectives. Microbiol Spectr 6.
  53. 53.↵
    Parker BW, Schwessinger EA, Jakob U, Gray MJ. 2013. The RclR protein is a reactive chlorine-specific transcription factor in Escherichia coli. J Biol Chem 288:32574–84.
    OpenUrlAbstract/FREE Full Text
  54. 54.↵
    Loi VV, Busche T, Tedin K, Bernhardt J, Wollenhaupt J, Huyen NTT, Weise C, Kalinowski J, Wahl MC, Fulde M, Antelmann H. 2018. Redox-Sensing Under Hypochlorite Stress and Infection Conditions by the Rrf2-Family Repressor HypR in Staphylococcus aureus. Antioxid Redox Signal 29:615–636.
    OpenUrl
  55. 55.↵
    Gennaris A, Ezraty B, Henry C, Agrebi R, Vergnes A, Oheix E, Bos J, Leverrier P, Espinosa L, Szewczyk J, Vertommen D, Iranzo O, Collet JF, Barras F. 2015. Repairing oxidized proteins in the bacterial envelope using respiratory chain electrons. Nature 528:409–412.
    OpenUrlCrossRef
  56. 56.↵
    Chi BK, Gronau K, Mader U, Hessling B, Becher D, Antelmann H. 2011. S- bacillithiolation protects against hypochlorite stress in Bacillus subtilis as revealed by transcriptomics and redox proteomics. Mol Cell Proteomics 10:M111 009506.
    OpenUrl
  57. 57.↵
    Motomura K, Hirota R, Okada M, Ikeda T, Ishida T, Kuroda A. 2014. A new subfamily of polyphosphate kinase 2 (class III PPK2) catalyzes both nucleoside monophosphate phosphorylation and nucleoside diphosphate phosphorylation. Appl Environ Microbiol 80:2602–8.
    OpenUrlAbstract/FREE Full Text
  58. 58.↵
    Zhang H, Ishige K, Kornberg A. 2002. A polyphosphate kinase (PPK2) widely conserved in bacteria. Proc Natl Acad Sci U S A 99:16678–83.
    OpenUrlAbstract/FREE Full Text
  59. 59.↵
    Delmas F, Pierre F, Coucheney F, Divies C, Guzzo J. 2001. Biochemical and physiological studies of the small heat shock protein Lo18 from the lactic acid bacterium Oenococcus oeni. J Mol Microbiol Biotechnol 3:601–10.
    OpenUrlPubMed
  60. 60.↵
    Coucheney F, Gal L, Beney L, Lherminier J, Gervais P, Guzzo J. 2005. A small HSP, Lo18, interacts with the cell membrane and modulates lipid physical state under heat shock conditions in a lactic acid bacterium. Biochim Biophys Acta 1720:92–8.
    OpenUrlCrossRefPubMedWeb of Science
  61. 61.↵
    Weidmann S, Maitre M, Laurent J, Coucheney F, Rieu A, Guzzo J. 2017. Production of the small heat shock protein Lo18 from Oenococcus oeni in Lactococcus lactis improves its stress tolerance. Int J Food Microbiol 247:18–23.
    OpenUrl
  62. 62.↵
    Serrano LM, Molenaar D, Wels M, Teusink B, Bron PA, de Vos WM, Smid EJ. 2007. Thioredoxin reductase is a key factor in the oxidative stress response of Lactobacillus plantarum WCFS1. Microb Cell Fact 6:29.
  63. 63.↵
    Kono Y, Fridovich I. 1983. Isolation and characterization of the pseudocatalase of Lactobacillus plantarum. J Biol Chem 258:6015–9.
    OpenUrlAbstract/FREE Full Text
  64. 64.↵
    Deborde M, von Gunten U. 2008. Reactions of chlorine with inorganic and organic compounds during water treatment-Kinetics and mechanisms: a critical review. Water Res 42:13–51.
    OpenUrlCrossRefPubMed
  65. 65.↵
    Gray MJ, Wholey WY, Parker BW, Kim M, Jakob U. 2013. NemR is a Bleach-Sensing Transcription Factor. J Biol Chem 288:13789–13798.
    OpenUrlAbstract/FREE Full Text
  66. 66.↵
    Serata M, Kiwaki M, Iino T. 2016. Functional analysis of a novel hydrogen peroxide resistance gene in Lactobacillus casei strain Shirota. Microbiology 162:1885–1894.
    OpenUrl
  67. 67.↵
    Deng DM, Liu MJ, ten Cate JM, Crielaard W. 2007. The VicRK system of Streptococcus mutans responds to oxidative stress. J Dent Res 86:606–10.
    OpenUrlCrossRefPubMed
  68. 68.↵
    Hillion M, Antelmann H. 2015. Thiol-based redox switches in prokaryotes. Biol Chem 396:415–44.
    OpenUrlCrossRefPubMed
  69. 69.↵
    Seaver LC, Imlay JA. 2001. Alkyl hydroperoxide reductase is the primary scavenger of endogenous hydrogen peroxide in Escherichia coli. J Bacteriol 183:7173–81.
    OpenUrlAbstract/FREE Full Text
  70. 70.↵
    Tachon S, Brandsma JB, Yvon M. 2010. NoxE NADH oxidase and the electron transport chain are responsible for the ability of Lactococcus lactis to decrease the redox potential of milk. Appl Environ Microbiol 76:1311–9.
    OpenUrlAbstract/FREE Full Text
  71. 71.↵
    Lenhart JS, Schroeder JW, Walsh BW, Simmons LA. 2012. DNA repair and genome maintenance in Bacillus subtilis. Microbiol Mol Biol Rev 76:530–64.
    OpenUrlAbstract/FREE Full Text
  72. 72.↵
    Kullin B, Tannock GW, Loach DM, Kimura K, Abratt VR, Reid SJ. 2014. A functional analysis of the formyl-coenzyme A (frc) gene from Lactobacillus reuteri 100-23C. J Appl Microbiol 116:1657–67.
    OpenUrl
  73. 73.↵
    Drazic A, Miura H, Peschek J, Le Y, Bach NC, Kriehuber T, Winter J. 2013. Methionine oxidation activates a transcription factor in response to oxidative stress. Proc Natl Acad Sci U S A 110:9493–9498.
    OpenUrlAbstract/FREE Full Text
  74. 74.↵
    Martinez-Antonio A, Collado-Vides J. 2003. Identifying global regulators in transcriptional regulatory networks in bacteria. Curr Opin Microbiol 6:482–9.
    OpenUrlCrossRefPubMedWeb of Science
  75. 75.↵
    Russo P, de la Luz Mohedano M, Capozzi V, de Palencia PF, Lopez P, Spano G, Fiocco D. 2012. Comparative proteomic analysis of Lactobacillus plantarum WCFS1 and DeltactsR mutant strains under physiological and heat stress conditions. Int J Mol Sci 13:10680–96.
    OpenUrlCrossRefPubMed
  76. 76.↵
    Elsholz AK, Gerth U, Hecker M. 2010. Regulation of CtsR activity in low GC, Gram+ bacteria. Adv Microb Physiol 57:119–44.
    OpenUrlCrossRefPubMed
  77. 77.↵
    Gray MJ, Wholey WY, Wagner NO, Cremers CM, Mueller-Schickert A, Hock NT, Krieger AG, Smith EM, Bender RA, Bardwell JC, Jakob U. 2014. Polyphosphate is a primordial chaperone. Mol Cell 53:689–99.
    OpenUrlCrossRefPubMedWeb of Science
  78. 78.↵
    Winter J, Ilbert M, Graf PC, Ozcelik D, Jakob U. 2008. Bleach activates a redox-regulated chaperone by oxidative protein unfolding. Cell 135:691–701.
    OpenUrlCrossRefPubMedWeb of Science
  79. 79.↵
    Sineva E, Savkina M, Ades SE. 2017. Themes and variations in gene regulation by extracytoplasmic function (ECF) sigma factors. Curr Opin Microbiol 36:128–137.
    OpenUrlCrossRefPubMed
  80. 80.↵
    Iobbi-Nivol C, Leimkuhler S. 2013. Molybdenum enzymes, their maturation and molybdenum cofactor biosynthesis in Escherichia coli. Biochim Biophys Acta 1827:1086–101.
    OpenUrlCrossRefWeb of Science
  81. 81.↵
    Gottesman S. 2017. Stress Reduction, Bacterial Style. J Bacteriol 199.
  82. 82.↵
    Gray MJ, Jakob U. 2015. Oxidative stress protection by polyphosphate--new roles for an old player. Curr Opin Microbiol 24:1–6.
    OpenUrlCrossRefPubMed
  83. 83.↵
    Rao NN, Gomez-Garcia MR, Kornberg A. 2009. Inorganic polyphosphate: essential for growth and survival. Annu Rev Biochem 78:605–47.
    OpenUrlCrossRefPubMedWeb of Science
  84. 84.↵
    Bsat N, Herbig A, Casillas-Martinez L, Setlow P, Helmann JD. 1998. Bacillus subtilis contains multiple Fur homologues: identification of the iron uptake (Fur) and peroxide regulon (PerR) repressors. Mol Microbiol 29:189–98.
    OpenUrlCrossRefPubMedWeb of Science
  85. 85.↵
    Alcantara C, Coll-Marques JM, Jadan-Piedra C, Velez D, Devesa V, Zuniga M, Monedero V. 2018. Polyphosphate in Lactobacillus and Its Link to Stress Tolerance and Probiotic Properties. Front Microbiol 9:1944.
  86. 86.↵
    Alcantara C, Blasco A, Zuniga M, Monedero V. 2014. Accumulation of polyphosphate in Lactobacillus spp. and its involvement in stress resistance. Appl Environ Microbiol 80:1650–9.
    OpenUrlAbstract/FREE Full Text
  87. 87.
    Sakatani A, Fujiya M, Ueno N, Kashima S, Sasajima J, Moriichi K, Ikuta K, Tanabe H, Kohgo Y. 2016. Polyphosphate Derived from Lactobacillus brevis Inhibits Colon Cancer Progression Through Induction of Cell Apoptosis. Anticancer Res 36:591–8.
    OpenUrlAbstract/FREE Full Text
  88. 88.
    Segawa S, Fujiya M, Konishi H, Ueno N, Kobayashi N, Shigyo T, Kohgo Y. 2011. Probiotic-derived polyphosphate enhances the epithelial barrier function and maintains intestinal homeostasis through integrin-p38 MAPK pathway. PLoS One 6:e23278.
  89. 89.
    Tanaka K, Fujiya M, Konishi H, Ueno N, Kashima S, Sasajima J, Moriichi K, Ikuta K, Tanabe H, Kohgo Y. 2015. Probiotic-derived polyphosphate improves the intestinal barrier function through the caveolin-dependent endocytic pathway. Biochem Biophys Res Commun 467:541–8.
    OpenUrl
  90. 90.↵
    Kashima S, Fujiya M, Konishi H, Ueno N, Inaba Y, Moriichi K, Tanabe H, Ikuta K, Ohtake T, Kohgo Y. 2015. Polyphosphate, an active molecule derived from probiotic Lactobacillus brevis, improves the fibrosis in murine colitis. Transl Res 166:163–75.
    OpenUrl
  91. 91.↵
    Wang L, Yan J, Wise MJ, Liu Q, Asenso J, Huang Y, Dai S, Liu Z, Du Y, Tang D. 2018. Distribution Patterns of Polyphosphate Metabolism Pathway and Its Relationships With Bacterial Durability and Virulence. Front Microbiol 9:782.
  92. 92.↵
    Achbergerova L, Nahalka J. 2014. PPK1 and PPK2 – which polyphosphate kinase is older? Biologia 69:263—269.
    OpenUrl
  93. 93.↵
    Dahl JU, Gray MJ, Bazopoulou D, Beaufay F, Lempart J, Koenigsknecht MJ, Wang Y, Baker JR, Hasler WL, Young VB, Sun D, Jakob U. 2017. The anti-inflammatory drug mesalamine targets bacterial polyphosphate accumulation. Nat Microbiol 2:16267.
    OpenUrl
  94. 94.↵
    van Pijkeren JP, Britton RA. 2012. High efficiency recombineering in lactic acid bacteria. Nucleic Acids Res 40:e76.
  95. 95.↵
    Edgar R, Domrachev M, Lash AE. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30:207–10.
    OpenUrlCrossRefPubMedWeb of Science
Back to top
PreviousNext
Posted April 11, 2019.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Complex responses to inflammatory oxidants by the probiotic bacterium Lactobacillus reuteri
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Complex responses to inflammatory oxidants by the probiotic bacterium Lactobacillus reuteri
Poulami Basu Thakur, Abagail R. Long, Benjamin J. Nelson, Ranjit Kumar, Alexander F. Rosenberg, Michael J. Gray
bioRxiv 605881; doi: https://doi.org/10.1101/605881
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Complex responses to inflammatory oxidants by the probiotic bacterium Lactobacillus reuteri
Poulami Basu Thakur, Abagail R. Long, Benjamin J. Nelson, Ranjit Kumar, Alexander F. Rosenberg, Michael J. Gray
bioRxiv 605881; doi: https://doi.org/10.1101/605881

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Microbiology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4113)
  • Biochemistry (8816)
  • Bioengineering (6519)
  • Bioinformatics (23463)
  • Biophysics (11791)
  • Cancer Biology (9209)
  • Cell Biology (13324)
  • Clinical Trials (138)
  • Developmental Biology (7439)
  • Ecology (11410)
  • Epidemiology (2066)
  • Evolutionary Biology (15151)
  • Genetics (10438)
  • Genomics (14044)
  • Immunology (9171)
  • Microbiology (22155)
  • Molecular Biology (8812)
  • Neuroscience (47570)
  • Paleontology (350)
  • Pathology (1428)
  • Pharmacology and Toxicology (2491)
  • Physiology (3730)
  • Plant Biology (8081)
  • Scientific Communication and Education (1437)
  • Synthetic Biology (2221)
  • Systems Biology (6038)
  • Zoology (1253)